Agritek Holdings (OTCQB:AGTK) announced its licensing partner 1919 Clinic obtained preliminary approval for a manufacturing and cultivation license in Puerto Rico.
As quoted in the press release:

Agritek Holdings presently holds a five year exclusive operational agreement with the Puerto Rico-based licensee 1919 Clinic with the Company providing funding for infrastructure build out, cultivation partners, equipment lease financing and product brand licenses. The final issuance of the manufacturing license will allow the operation to produce edibles and extraction services for other cultivators as well as oils for cartridges supplied by Agritek.
Agritek Holdings has already started to receive rental income since May 2017 and will receive residual income throughout the term of the agreement on all infrastructure loans, product licensing and cultivation consulting. B. Michael Friedman, CEO for Agritek, stated, “Puerto Rico in my opinion as a US territory has very unique status, and with our guidance and innovations for the 25,000 square foot facility in the middle of the city of San Juan will set the standard for compliance, growing technology and consistency of medicine. We have already started to infuse funds for infrastructure build out and security systems under the guidelines of the Department of Health and plan to make 1919 Clinic the gold standard for the island.”
“Puerto Rico, similar to Nevada, has set guidelines to be a territory of reciprocity where patients holding cards from other regulated states will be able to purchase medicine during their travel. With Puerto Rico being one of the top destinations for the cruise ship industry, we believe the stage is being set for Puerto Rico to be a meaningful and newly emerging medical market for the cannabis sector. Agritek will be bringing our expertise, including cultivation teams from Colorado and California, to technology and new product brands, creating jobs, innovation, compliance and meaningful revenue for the Puerto Rico economy,” further stated Friedman.


Click here to read the full press release.

Source: www.marketwired.com

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/

Avicanna Inc. (the “ Company ” or “ Avicanna ”) (TSX: AVCN) announced today that it has been issued a Cease Trade Order (“ CTO ”) by the Ontario Securities Commission (the “ OSC ”) as it no longer expects to file the following periodic disclosure documents (collectively, the “ Documents ”) by June 11, 2021, as previously disclosed:

Keep reading... Show less

Adds two accomplished female directors to the Board

Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the results of its Annual and Special Meeting of Shareholders held on June 10, 2021 (the “Meeting”). Each of the eight individuals nominated for election as a director of Trulieve at the Meeting were elected, including new nominees, Giannella Alvarez and Jane Morreau .

Keep reading... Show less

The National Football League (NFL) wants to know more about cannabis as a pain reliever, and it’s willing to put up an initial US$1 million for research.

Also this week, a cannabis operator announced plans to buy assets from a languishing producer.

Keep reading... Show less

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a new Florida dispensary, the Company’s 89th nationwide.

The dispensary will be located next to the Citrus Park Town Center and helps meet Trulieve’s goal of ensuring medical cannabis patients across Florida have safe, reliable access to the medications they rely on. The facility joins four other Tampa dispensaries, as well as several more in nearby Clearwater , St. Petersburg , and Largo.

Keep reading... Show less

On June 10, 2021, RCP23, LLC (the “Seller”), a private investment holding company controlled by Benjamin Kovler, CEO and Chairman of Green Thumb Industries Inc. (the “Issuer”) (CSE: GTII) (OTCQX: GTBIF), sold 1,666,667 Subordinate Voting Shares of the Issuer (the “Transferred Shares”) to a third-party qualified institutional buyer at a purchase price of US$30.00 per share in a private transaction.

“This transaction brings Green Thumb a new institutional shareholder who is aligned with management’s long-term vision,” said Manager of RCP23 Benjamin Kovler.  “RCP23 has historically sold shares on behalf of our legacy shareholders who invested prior to Green Thumb going public.”

Keep reading... Show less